IPP Bureau

Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies
Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies

By IPP Bureau - June 05, 2026

Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments

Aurobindo Pharma receives USFDA nod for generic Tofacitinib tablets
Aurobindo Pharma receives USFDA nod for generic Tofacitinib tablets

By IPP Bureau - June 05, 2026

Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval

Suven Life reports positive interim review for phase 3 Alzheimer’s therapy
Suven Life reports positive interim review for phase 3 Alzheimer’s therapy

By IPP Bureau - June 05, 2026

Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial

Kaushik Deb elevated to Vice President at Mankind Pharma
Kaushik Deb elevated to Vice President at Mankind Pharma

By IPP Bureau - June 05, 2026

Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth

CBC India partners with Metalco-Alupack to strengthen pharma aluminium packaging solutions
CBC India partners with Metalco-Alupack to strengthen pharma aluminium packaging solutions

By IPP Bureau - June 05, 2026

Exclusive partnership to expand access to high-quality seamless anodized aluminium packaging for sterile APIs and pharmaceutical products across India.

Glenmark launches generic Lacosamide Injection USP in US Market
Glenmark launches generic Lacosamide Injection USP in US Market

By IPP Bureau - June 05, 2026

Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually

Rahul Pasumarthy joins Apollo Hospitals as Vice President – Apollo International
Rahul Pasumarthy joins Apollo Hospitals as Vice President – Apollo International

By IPP Bureau - June 05, 2026

Healthcare industry leader returns to India to support Apollo Hospitals’ global expansion and advance the ‘Heal in India, Heal by India’ vision

Aurobindo Pharma launches TheraNym, India’s largest biologics CMO
Aurobindo Pharma launches TheraNym, India’s largest biologics CMO

By IPP Bureau - June 05, 2026

MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market

CORONA Remedies spearheads green footprint campaign on World Environment Day
CORONA Remedies spearheads green footprint campaign on World Environment Day

By IPP Bureau - June 05, 2026

The company recycled approximately 100 kilograms of textile waste, undertook plantation activities, and encouraged employees to adopt environmentally responsible practices

Finerenone expands promise beyond diabetic kidney disease
Finerenone expands promise beyond diabetic kidney disease

By IPP Bureau - June 05, 2026

The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized

Wanbury FY26 PAT surges 117% to Rs. 66.1 crore
Wanbury FY26 PAT surges 117% to Rs. 66.1 crore

By IPP Bureau - June 05, 2026

SS Innovations sets world record with longest-distance robotic cardiac telesurgery
SS Innovations sets world record with longest-distance robotic cardiac telesurgery

By IPP Bureau - June 05, 2026

The robotic cardiac procedure between Guyana and India, established a new benchmark in global telesurgery across nearly 20,000 kilometres

Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment
Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment

By IPP Bureau - June 05, 2026

Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe

Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials
Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials

By IPP Bureau - June 05, 2026

Targeting deadly drug-resistant acinetobacter infections

Muthukumar Anbalagan joins Intas Pharma as General Manager – NDDS
Muthukumar Anbalagan joins Intas Pharma as General Manager – NDDS

By IPP Bureau - June 05, 2026

Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness

Latest Stories

Interviews

Packaging